Seligman Henry, Sen Sayan, Nijjer Sukhjinder, Al-Lamee Rasha, Clifford Piers, Sethi Amarjit, Hadjiloizou Nearchos, Kaprielian Raffi, Ramrakha Punit, Bellamy Michael, Khan Masood A, Kooner Jaspal, Foale Rodney A, Mikhail Ghada, Baker Christopher S, Mayet Jamil, Malik Iqbal, Khamis Ramzi, Francis Darrel, Petraco Ricardo
Imperial College Healthcare NHS Trust London, UK.
National Heart and Lung Institute Imperial College London, UK.
Interv Cardiol. 2020 Nov 24;15:e16. doi: 10.15420/icr.2020.21. eCollection 2020 Apr.
Coronavirus disease 2019 (COVID-19) is forcing cardiology departments to rapidly adapt existing clinical guidelines to a new reality and this is especially the case for acute coronary syndrome pathways. In this focused review, the authors discuss how COVID-19 is affecting acute cardiology care and propose pragmatic guideline modifications for the diagnosis and management of acute coronary syndrome patients, particularly around the appropriateness of invasive strategies as well as length of hospital stay. The authors also discuss the use of personal protective equipment for healthcare workers in cardiology. Based on shared global experiences and growing peer-reviewed literature, it is possible to put in place modified acute coronary syndrome treatment pathways to offer safe pragmatic decisions to patients and staff.
2019冠状病毒病(COVID-19)正迫使心脏病学部门迅速将现有的临床指南应用于新的实际情况,急性冠状动脉综合征诊疗路径尤其如此。在这篇重点综述中,作者讨论了COVID-19如何影响急性心脏病治疗,并针对急性冠状动脉综合征患者的诊断和管理提出了务实的指南修订建议,特别是关于侵入性策略的合理性以及住院时间。作者还讨论了心脏病学医护人员个人防护装备的使用。基于全球共同经验和不断增加的同行评审文献,有可能制定经修订的急性冠状动脉综合征治疗路径,为患者和医护人员提供安全务实的决策。